Squarepoint Ops LLC Immunity Bio, Inc. Transaction History
Squarepoint Ops LLC
- $62.8 Billion
- Q3 2024
A detailed history of Squarepoint Ops LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 109,485 shares of IBRX stock, worth $491,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,485
Previous 60,936
79.67%
Holding current value
$491,587
Previous $385,000
5.45%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IBRX
# of Institutions
202Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$75.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$51.3 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$38.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$17.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$10.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.8B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...